insights_auto
Why is ALLO down 8,12%?
Dive Deeperchevron_right
ALLO:NASDAQ
Allogene Therapeutics Inc
0,83 US$
arrow_downward
-8,12%(-0,073) 1D
0,83 US$
arrow_upward
+0,37% (+0,0031)todayPre-market
Closed: 12 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALLO...
Open
0,89 US$
High
0,90 US$
Low
0,82 US$
Mkt. cap
286,56 მლნ.
Avg. vol.
9,22 მლნ.
Volume
25,55 ათ.
52-wk high
4,46 US$
52-wk low
0,82 US$
EPS
-0,62 US$
Beta
0,76
Shares outstanding
346,47 მლნ.
No. of employees
150
Open
0,89 US$
High
0,90 US$
Low
0,82 US$
Mkt. cap
286,56 მლნ.
Avg. vol.
9,22 მლნ.
Volume
25,55 ათ.
52-wk high
4,46 US$
52-wk low
0,82 US$
EPS
-0,62 US$
Beta
0,76
Shares outstanding
346,47 მლნ.
No. of employees
150
News stories
From web sources and news partners
Investing.com
·
8 წუთის წინ
Goldman’s Oppenheimer sees S&P 500 advancing to 8,700 in 2027
Seeking Alpha
·
14 წუთის წინ
Buckle Up - The S&P 500 Is Failing The Oldest Test In Investing
Traders Union
·
10 წუთის წინ
Aptos weekly outlook: Options listing on Nasdaq ISE fails to lift sentiment—can APT escape downside bias?
Reuters
·
1 საათის წინ
Nasdaq futures dip as Nvidia tumult keeps investors on edge
About Allogene Therapeutics Inc
CEO-
Employees150
Founded2017
HeadquartersSouth San Francisco, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websiteallogene.com